Oral candidiasis epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 11: | Line 11: | ||
*There is a higher incidence among neonates and African-Americans. | *There is a higher incidence among neonates and African-Americans. | ||
*OPC used to be a common opportunistic infection in [[HIV]]-infected persons (prior to the introduction of highly active antiretroviral therapy [[HAART]]). | *OPC used to be a common opportunistic infection in [[HIV]]-infected persons (prior to the introduction of highly active antiretroviral therapy [[HAART]]). | ||
*Nosocomial disease surveillance is conducted by NNIS in selected hospitals. Active population-based surveillance for candidemia is being conducted in selected U.S. sites. | |||
==References== | ==References== |
Revision as of 15:19, 2 January 2013
Oral candidiasis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Oral candidiasis epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Oral candidiasis epidemiology and demographics |
Risk calculators and risk factors for Oral candidiasis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Epidemiology and Demographics
- The infection is not very common in the general population.
- It is estimated that between 5% and 7% of infants less than one month old will develop oral candidiasis.
- The prevalence of oral candidiasis among AIDS patients is estimated to be between 9% and 31%, and studies have documented clinical evidence of oral candidiasis in nearly 20% of cancer patients.
- Thrush is the fourth most common cause of nosocomial bloodstream infections.
- The incidence is 8 cases per 100,000 in the general population.
- There is a higher incidence among neonates and African-Americans.
- OPC used to be a common opportunistic infection in HIV-infected persons (prior to the introduction of highly active antiretroviral therapy HAART).
- Nosocomial disease surveillance is conducted by NNIS in selected hospitals. Active population-based surveillance for candidemia is being conducted in selected U.S. sites.